Birchview Capital »

Candel Therapeutics shares owned by Birchview Capital

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Birchview Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $306k 60k 5.10
2025-06-30 $304k 60k 5.06
2025-03-31 $339k 60k 5.65
2024-12-31 $521k 60k 8.68